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Circadian rhythmicity in mammals is under the control of a molec-
ular pacemaker constituted of clock gene products organized in
transcriptional autoregulatory loops. Phase resetting of the clock in
response to light involves dynamic changes in the expression of
several clock genes. The molecular pathways used by light to
influence pacemaker-driven oscillation of clock genes remain
poorly understood. We explored the functional integration of both
light- and clock-responsive transcriptional regulation at the pro-
moter level of the Period (Per) genes. Three Per genes exist in the
mouse. Whereas mPer1 and mPer2 are light-inducible in clock
neurons of the hypothalamic suprachiasmatic nucleus, mPer3 is
not. We have studied the promoter structure of the three mPer
genes and compared their regulation. All three mPer promoters
contain E-boxes and respond to the CLOCKbrain and muscle aryl
hydrocarbon receptor nuclear translocator (ARNT)-like protein 1
(BMAL1) heterodimer. On the other hand, only mPer1 and mPer2
promoters contain bona fide cAMP-responsive elements (CREs)
that bind CRE-binding protein (CREB) from suprachiasmatic nucleus
protein extracts. The mPer1 promoter is responsive to synergistic
activation of the cAMP and mitogen-activated protein kinase
pathways, a physiological response that requires integrity of the
CRE. In contrast, activation of mPer promoters by CLOCKBMAL1
occurs regardless of an intact CRE. Altogether, these results con-
stitute strong evidence that CREB acts as a pivotal endpoint of
signaling pathways for the regulation of mPer genes. Our results
reveal that signaling-dependent activation of mPer genes is dis-
tinct from the CLOCKBMAL1-driven transcription required within
the clock feedback loop.
C ircadian rhythmicity is a conserved physiological feature ofalmost all organisms (1–3). Light is the most prominent
stimulus that has contributed in shaping circadian physiology
during evolution (4, 5). Through several photoreception systems,
light is capable of synchronizing circadian oscillations to the
environment (4, 6). In mammals the core pacemaker is located
in the suprachiasmatic nucleus (SCN) of the hypothalamus,
whose neurons receive photic input signals from the retina by
way of the retinohypothalamic tract (7).
Although several nonphotic stimuli have also been shown to
reset the mammalian circadian system (8–13), light is the major
entraining signal and it delays the pacemaker if administered at
early night and advances it at late night (6). The effect is
intimately connected to the clock mechanism because light has
no effect when applied during the subjective day. The process of
synchronization involves the transcriptional activation of several
genes. In mice, brief exposure to light during the subjective night
causes rapid induction of immediate-early genes, such as c-fos
(14), and of clock genes, such as the homologs of the Drosophila
period gene (15–17). Three period genes exist in the mouse, and
although mPer1 is induced by a light pulse within 15–30 min and
mPer2 within 2 h (15–17), the mPer3 gene is not light-responsive
(18, 19). Arousal (11) and serotonin receptor activation (20)
induce acute down-regulation of mPer1 and mPer2 expression in
the SCN, identifying them as common targets for both photic
and nonphotic cues.
Whereas mPer1 and mPer2 seem to play a crucial role in the
molecular organization of the pacemaker (21–25), mPer3 seem
to operate on clock output pathways (26). Per genes are known
to be positively regulated by other clock proteins belonging to the
basic helix-loop-helix–periodaryl hydrocarbon receptor nuclear
translocatorsingle-minded (PAS) class. These are CLOCK and
brain and muscle aryl hydrocarbon receptor nuclear translocator
(ARNT)-like protein 1 (BMAL1) which, associated as het-
erodimers, bind to E-box enhancer elements (27–29). In addi-
tion, mPER proteins constitute multimeric complexes with the
products of the Cryptochrome genes, mCRY1 and mCRY2, which
in turn inhibit transcription mediated by CLOCKBMAL1 (30,
31). The mPer genes exhibit circadian cycling expression in the
SCN (15, 19) and in several peripheral tissues, e.g., liver and
skeletal muscle (19, 32), and in cultured cell lines stimulated with
a number of stimuli (33–37).
Several lines of evidence indicate that the mPer1 gene plays a
central role in conveying the light-entraining information to the
central clock. mPer1 is the only clock gene that has been
convincingly shown to be induced very rapidly after light stim-
ulation (15–17, 38). In addition, light-induced resetting of loco-
motor activity and glutamate-induced resetting of firing rhythms
can be blocked by mPer1 antisense oligonucleotides (39). Finally,
some reports on mPer1-deficient mice confirm this view (40).
Although resetting of the circadian system seems to involve
changes in gene expression, little is known about the signal
transduction pathways that initiate this transcriptional response.
Signaling pathways for light-dependent clock resetting include
glutamate release from retinohypothalamic tract terminations
within the SCN, N-methyl-D-aspartate receptor activation, and
Ca2 influx (41, 42). Calcium influx may be linked to cAMP-
responsive element (CRE)-mediated transcription activated by
the extracellular signal-regulated kinase (ERK)-mitogen-
activated protein kinase (MAPK) pathway (43). Indeed, a light
pulse during the night activates the MAPK signaling cascade
(44) and consequently induces CRE-binding protein (CREB)
phosphorylation (45) in SCN neurons.
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We have studied the regulation of mPer promoters by signaling
stimuli. Our analysis has identified significant differences and
similarities among the three promoters. We demonstrate that
CREB acts as a major effector of converging signaling pathways
to the mPer1 promoter and that this regulation is independent of
CLOCKBMAL1 action.
Materials and Methods
Plasmids. The mPer1, mPer2, and mPer3 promoter regions were
isolated and cloned in pGL3-Basic Vector (Promega). The
mPer1 region spans from 1803 to 40 (1 is the putative
transcription start site), and the sequence is identical with that
in GenBank accession no. AB030818 (46). The mPer2 and
mPer3 regions are from1670 to53 and from1594 to128,
respectively, and were deposited in GenBank (accession nos.
AF491941 and AF491942). Mutation in the CREs within mPer1
and mPer2 promoters was generated by deletion of the central 4
nt (TGACGTCA3 TGCA). Oligonucleotides corresponding to
CRE-mPer1 (5-tccgcttTGACGTCAcctccct-3), CRE-mPer2
(5-ccaccatTGACGTCAatgtaag-3), or their mutated forms (5-
tccgctcTCACAAAAcctccct-3 and 5-ccaccgcTGACAAAatg-
taag-3) were inserted in the pGL3-Promoter Vector (Promega).
Mouse Clock ORF was amplified by PCR from a cDNA kindly
provided by J. Takahashi (Northwestern University, Chicago),
cloned in the pSG5 vector (Stratagene) with a FLAG epitope
sequences at the 5 end. Mouse Bmal1 was amplified by reverse
transcription–PCR from mouse brain RNA. This cDNA was
cloned in pCS2MTK, a derivative of pCS2 with five Myc-tag
sequences at the 5 end of the cDNA.
Cell Culture and Transient Transfections. Human choriocarcinoma
JEG3 cells were cultured in monolayers with Dulbecco’s mod-
ified Eagle’s medium (GIBCOBRL) supplemented with 10%
FCS. Cells were transfected by the calcium phosphate copre-
cipitation technique with 1 g of reporter construct. Medium
was replaced with 0.5% FCS medium 12–16 h before cells were
treated with various agents: forskolin (10 M), epidermal
growth factor (EGF; 50 ngml), 4-bromo-calcium ionophore
A23187 (1 M), phorbol 12-tetradecanoate 13-acetate (TPA)
(100 ngml), andor 20% FCS for 6 h before harvest. In specific
experiments inhibitors PD 98059 (30 M; Calbiochem) and SB
203580 (10 M; Calbiochem) were added to cells 1 h before
treatments. Luciferase activity was measured as described (47).
All experiments were performed in triplicate.
Nuclear Extract Preparation and DNA-Binding Assays. Adult male
Wistar rats were kept on a 12-h light:12-h dark cycle for 3 weeks
before dissection. SCNs and underlying optic chiasms were
isolated under the dissecting microscope. Blocks1 1 1 mm
were rapidly frozen in liquid nitrogen and stored at80°C. SCN
(48) and Rat-1 fibroblasts (49) nuclear extracts were prepared as
described. Western analyses and immunostaining were as de-
scribed (50) with anti-phospho-CREB or anti-CREB antibodies
(New England Biolabs). For the gel retardation assays, CRE
oligonucleotide probes or their mutated forms (same sequences
as above) were used as described (51). In competition or in
antibody-supershifting assays, unlabeled oligonucleotides or
anti-CREB, anti-ATF1, anti-ATF2 antibodies (Santa Cruz Bio-
technology) were added to the extracts 30 min before the labeled
oligonucleotides. Recombinant CREB was produced as
described (52).
Results
Similarities and Differences Between the mPer Promoters. We have
analyzed the sequence of the 5 f lanking regulatory regions of
the three mouse Per genes. Three CACGTG E-boxes and one
canonical CRE (TGACGTCA) are within 1,803 bp of the mPer1
gene promoter, centered at 1,728 bp upstream of the transcrip-
tion start site (Fig. 1). Within the 1,670-bp promoter region of
mPer2 and 1,594 bp of mPer3 genes, seven and four E-boxes
(CANNTG) were found, respectively (Fig. 1). None of these
E-boxes corresponds to the CACGTGA sequence, the strict
consensus binding site for CLOCKBMAL1 heterodimers (28).
A canonical CRE is also present within mPer2 promoter, but not
in the mPer3 promoter (Fig. 1). The CRE has a common location
within both mPer1 and mPer2 promoters, being consistently
upstream from the E-boxes. This reciprocal location of CREs
and E-boxes is characteristic also in promoters of other genes,
such as renin and transforming growth factor 2 (53, 54).
mPer1 and mPer2 CREs Bind CREB in SCN Nuclear Extract. The CREs
present in the promoters of the mPer1 and mPer2 genes effi-
ciently bind recombinant CREB protein, whereas their mutated
forms do not (Fig. 2A). A nuclear extract from Rat-1 fibroblasts
was also used to assess binding to the mPer1 CRE (Fig. 2B).
Specificity of binding was confirmed by competition with unla-
beled CRE oligonucleotides. The canonical somatostatin CRE
(55) and the mPer1 and mPer2 CREs successfully competed for
binding, whereas a mutated mPer1 CRE was not an effective
competitor. Analogous results were obtained with the mPer2
CRE (not shown). We also performed binding assays using
nuclear extracts from rat SCN collected at Zeitgeber time (ZT)
5 or ZT17, or 1 h after a 30-min light pulse at ZT17 (Fig. 2C).
SCN extracts display a robust CRE-binding activity. Complex
formation for both mPer1 and mPer2 CREs is constant inde-
pendent of circadian phase or photic stimulation. Binding spec-
ificity was assessed by competition with the somatostatin CRE.
To identify the nature of the natural mPer CRE-binding activity
supershift assays were performed with the SCN extracts.
Whereas preincubation with anti-CREB antibodies drastically
decreased complex formation on both mPer1 or mPer2 CREs,
neither anti-ATF1 nor anti-ATF2 antibodies had any effect (Fig.
2D). These results show that CREB naturally binds the mPer
promoter sequences in the SCN.
A light stimulus that phase-shifts circadian rhythms has been
shown to induce phosphorylation of CREB at Ser-133, a critical
event in transcriptional activation (45, 56). To link this notion to
the activation of mPer genes, we analyzed CREB phosphoryla-
tion in our SCN nuclear extracts. We used antibodies raised
against CREB phosphorylated at Ser-133 (45). CREB is phos-
phorylated at ZT5, but not at ZT17, and is induced by a light
pulse at ZT17 (Fig. 2E). These results implicate CREB as a
signaling-responsive switch for mPer1 transcriptional response in
the SCN.
Fig. 1. Schematic representation of mPer1, mPer2, and mPer3 promoters.
The upstream sequence of mPer1, mPer2, and mPer3 genes was fused to a
luciferase reporter. On the left is indicated the size of the genomic fragment
upstream of the transcription start site (1) that is included in the construc-
tion. The numbers below the box representing the promoter sequence are the
positions of the CRE (TGACGTCA) and E-boxes (small white boxes).









Distinct Effects of CLOCKBMAL1 and Signaling Pathways on mPer
Promoter Activation. Cotransfection of JEG-3 cells with mPer1,
mPer2, and mPer3 promoter reporters along with CLOCK and
BMAL1 expression vectors resulted in transcriptional stimula-
tion of all three mPer promoters (Fig. 3A), as reported for mPer1
(27). CLOCKBMAL1-dependent activation of mPer1 is signif-
icantly higher than mPer2 and mPer3.
To explore the ability of mPer promoters to respond to
stimulation of different signaling pathways, we treated trans-
fected cells with adenylate cyclase activator forskolin, EGF,
4-bromo-calcium ionophore A23187, TPA, and 20% FCS. Only
forskolin caused significant elevation of mPer1 promoter activity
(Fig. 3B). However, remarkable up-regulation was observed
when cells were concurrently treated with forskolin and EGF or
TPA. These results indicate that maximal induction of mPer1
promoter activity requires a cooperative activation of both
cAMP and MAPK pathways. No response was observed for
either mPer2 or mPer3 after treatments (Fig. 3B), which is
noteworthy considering the similarity in the organization of
mPer1 and mPer2 promoters (Fig. 1) and the capacity of the
mPer2 CRE to bind CREB (Fig. 2).
Essential Role of the mPer1 CRE in the Response to Signaling
Inducers. To assess the role played by the CRE in the remark-
able responsiveness of the mPer1 promoter, we generated a
deletion of the four internal nucleotides of the CRE within the
context of the whole mPer1 promoter (Fig. 4A). This mutation
of the CRE abolishes CREB binding (not shown) and fully
blocks responsiveness of the mPer1 promoter (Fig. 4A). This
result underscores the importance of the CRE in signaling
Fig. 2. Specific binding of CREB to wild-type CRE of mPer1 and mPer2 promoters. (A) Gel mobility-shift assay using wild-type or mutated mPer1 or mPer2 CRE
oligonucleotides, plus bacterially expressed CREB protein. The specific complex is indicated by an arrowhead. (B) Competition gel mobility-shift assay using
labeled mPer1 CRE oligonucleotide together with nuclear extract from Rat-1 fibroblasts. Competition is made by preincubating the labeled DNA with increasing
amounts (20–500 ng) of unlabeled wild-type mPer1, mPer2, or somatostatin CRE or mutated mPer1 oligonucleotides. The specific complex is indicated by an
arrowhead. (C) Gel mobility-shift assay using mPer1 or mPer2 CRE oligonucleotides along with nuclear extracts from the SCN of rats killed during the day (ZT5),
and during the night (ZT17) either in the darkness or 1 h after the beginning of a 30-min light pulse. (D) Supershift assay on SCN nuclear extracts with mPer1
or mPer2 CRE after preincubation of SCN nuclear extract with anti-CREB, anti-ATF1, and anti-ATF2 antibodies. The specific complex is indicated by a closed
arrowhead and the supershifted by an open arrowhead. The first lane is the control without antibody and the second lane is a complex with mutated
oligonucleotide. (E) Immunoblotting of SCN protein extracts from rats killed as in C, with an anti-phosphorylated CREB (P-CREB) antibody. ‘‘C’’ is a control
containing P-CREB (EGF-stimulated fibroblasts).
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response and demonstrates that the rest of the mPer1
promoter, including the E-boxes, is not sufficient to elicit
inducibility.
The functional importance of the CRE was further verified by
using the isolated mPer1 and mPer2 CRE sequences inserted in
heterologous promoter reporters. The mPer1 CRE confers
remarkable responsiveness on stimulation with forskolin, EGF,
TPA, or serum, and synergistic activation after combined treat-
ments, analogous to what was observed with the full mPer1
promoter. All responses were abolished when the CRE was
mutated (Fig. 4B). Thus, the CRE alone is capable of conveying
MAPK- and cAMP-inducible activation and could thereby
constitute a link between light-stimulated MAPK pathway and
light induction of the mPer1 gene. When isolated, the CRE of
mPer2 promoter can also serve as a target site of activated
signaling pathways, especially cAMP (Fig. 3B). This observation
suggests that additional sequences within the mPer2 promoter
may modulate the responsiveness of the CRE.
MAPK Cascade Inhibitors Block mPer1 EGF and TPA Inducibility.
Phosphorylation of CREB in the SCN in response to a light
stimulus has been proposed to depend on the MAPK pathway
(43). To examine the specificity of mPer1 stimulation by EGF
and TPA, we treated cells transfected with the full-length mPer1
promoter with the specific MEK inhibitor PD 98059 1 h before
stimulation (Fig. 5). Inhibition of MEKs blocks the synergistic
activation of the mPer1 promoter by concurrent application of
EGF or TPA and forskolin. However, forskolin-dependent
activation is not affected, stressing the independence from
MAPKs of the cAMP-inducible activation. These results suggest
the convergence of multiple signaling routes whose effects are
integrated at the level of the mPer1 promoter. In support of this
interpretation, SB 203580, a specific inhibitor of the p38 MAPK
cascade, also significantly inhibits EGF- and TPA-mediated
activation of mPer1. As for the inhibitor PD 98059, cAMP
inducibility of mPer1 is not affected by SB 203580.
Activation by CLOCKBMAL1 Is Independent of the CREs. We wished
to establish whether signaling-dependent induction through the
CRE would influence the clock-controlled CLOCKBMAL1
activation. We used the full-length mPer1 and mPer2 promoters
containing either an intact or a mutated CRE in cotransfection
experiments with CLOCK and BMAL1 expression vectors. The
results clearly show that CLOCKBMAL1 activation does not
require the CRE (Fig. 6). This finding indicates that specific,
independent sequences within the mPer1 promoter integrate
signaling stimuli and clock-dependent regulation.
Fig. 3. Activation of mPer1, mPer2, and mPer3 promoters by CLOCKBMAL1 and by the induction of different signaling pathways. (A) JEG-3 cells were
transfected with a construct of the mPer promoter regions linked to the luciferase reporter gene and either CLOCK or BMAL1 alone or together. Cells were
washed after 12 h and processed for luciferase assay 24 h later. (B) For stimulation, cells transfected with either of the mPer promoter constructs were treated
with forskolin (10M), EGF (50 ngml), 4-bromo-calcium ionophore A23187 (1M), TPA (100 ngml), 20% fetal calf serum, or combinations. Six hours later, cells
were harvested for luciferase assay. Data are expressed as fold increase over the value for unstimulated cells. Each bar represents the mean and SEM of three
independent samples. The figures are representative from several independent experiments with similar results.
Fig. 4. Mutation within CRE abolishes the response of the promoter to cell-signaling stimulation. JEG-3 cells were transfected with a luciferase construct with
either wild-type or CRE-mutated mPer1 promoter (A), or with isolated wild-type or mutated CRE motifs of mPer1 and mPer2 promoters (B). Stimulation and
luciferase assays were done as in Fig. 3.










The pathways that light uses to impinge on the clock molecular
mechanism are still poorly understood. We reasoned that study-
ing how the expression of clock genes is regulated by intracellular
signaling systems would provide useful information in this
respect. The mPer genes have been shown to respond differen-
tially to light in the SCN (15, 16, 18, 19, 38). mPer1 is induced
quickly, with kinetics of an immediate-early gene; mPer2 re-
sponds more slowly, reaching peak values 2–3 h after the light
stimulus; mPer3 is not light-responsive. Our results on the
inducibility of the mPer promoters by various signaling agents
establish an interesting parallel with light responsiveness.
Whereas mPer1 and mPer2 contain a CRE, mPer3 does not (Fig.
1). The absence of a CRE in the mPer3 promoter is likely to be
linked to its uninducibility by activation of the cAMP and MAPK
pathways. Although the mPer2 regulatory region contains a
canonical and functional CRE, the promoter is poorly respon-
sive, in sharp contrast to mPer1 (Fig. 3). It seems that the mPer2
CRE is functional, but that in the context of the whole promoter
it becomes inactivated. This different activation potential of
mPer1 and mPer2 CREs could account for the diverse induction
kinetics of the two genes in the SCN of light-stimulated animals.
One possibility is that newly synthesized factors are needed for
the induction of mPer2 in the SCN, which would explain its
delayed kinetics of induction. These de novo synthesized proteins
may be lacking in our cell-based system. Another aspect to take
into account is the likely interactions that CREB may have with
additional factors regulating the mPer promoters, including
E-box-binding proteins, because these interactions may modu-
late responsiveness of the promoter. In this respect the combined
presence of CREs and E-boxes in several promoters is notewor-
thy (53, 54). The CRE is often placed upstream from the
E-boxes, suggesting a code of possible protein–protein interac-
tions. Yet direct interactions of CREB with E-box-binding
proteins have not been described. We have shown that CLOCK
BMAL1-dependent activation is independent of the CRE
(Fig. 7).
The involvement of CREB in light-induced clock resetting is
based on the observation that CREB becomes phosphorylated
in vivo in response to photic stimuli (45), and in vitro after
glutamate treatment (57). Furthermore, light exposure at night,
when it causes phase shifts of overt rhythms, elicited a robust
increase in CRE-mediated transcription in the retinorecipient
part of the SCN (43). Here we have established a direct link
between intracellular signaling, CRE-regulated transcription,
and mPer gene expression. It is important to explore the role
played by the CREB coactivator CBP (CREB-binding protein)
in SCN neurons, because it has been shown that CBP itself is a
target of signaling regulation (56).
CREB activation by phosphorylation at Ser-133 occurs in
response to several signaling stimuli, including the ERK-MAPK
pathway (58, 59). In the SCN, stimulation of these kinases occurs
after a light pulse that would shift the clock (44) and contributes
to activation of CREB by glutamate (43). A variety of treatments
trigger expression of endogenous Per1 and other clock and
clock-controlled genes in mammalian cell lines (33–37, 60). Our
results identify the cAMP and MAPK pathways, and their
synergistic combination, as essential for CRE-mediated induc-
tion of mPer1. Future studies will need to focus on the important
issue of how these signaling pathways are modulated within SCN
neurons. Phosphorylation and dephosphorylation of specific
nuclear substrates, including CREB and histone H3 tail (45, 50,
56), are essential in the fine tuning of transcription regulation.
This study provides further support to the hypothesis that
light-induced resetting of the clock proceeds by activation of Per
genes, namely mPer1 (15, 16, 38, 39). It is still unclear how the
same mPer1 activation gives rise to different responses depend-
ing on the time in the circadian cycle (16, 50, 61). The changing
phase relationships of clock genes and relative protein abun-
dance likely play an important role in this respect (62). The
possibility that synergistic action of signaling routes, as well as
their known cross-talks, may occur at restricted temporal win-
Fig. 5. Inhibitors of MAPK cascades abolish synergistic activation of the
mPer1 promoter by forskolin and EGF or TPA. Transfection, treatments, and
luciferase analysis were conducted as in Fig. 3B, except that PD 98059 (30 M)
or SB 203580 (10 M) or the vehicle was applied to the cells 1 h before the
inducing treatments.
Fig. 6. Activation of mPer1 or mPer2 promoters by CLOCKBMAL1 is unaf-
fected by a CRE mutation. Cells were transfected with the wild-type or
CRE-mutated mPer1 or mPer2 promoter constructs, and with CLOCK and
BMAL1 expression plasmid or the empty vectors, and processed as in Fig. 3A.
Fig. 7. Schematic representation of the mPer1 promoter and its regulation.
While the E- boxes (only one is shown here) are targets of the clock-controlled
CLOCKBMAL1 regulation, the CRE is essential for response to various signal-
ing pathways.
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dows will need to be taken into account to decipher the
mechanisms of clock physiology.
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